drugset / Trial / NCT00744913

Study of Nicotine Replacement Therapy in Pregnancy

NCT00744913

Phase 3 Withdrawn The Hospital for Sick Children
RandomizedParallel-groupOpen-labelTreatment

Summary

The overall objective of this study is to assess the effectiveness of NRT (Nicoderm patches) plus counselling treatment in women in the second and third trimester of pregnancy.

Timeline

Start
2008-08
Primary completion
2010-02
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Unknown 14 mg Other
Subject Nicotine Unknown 21 mg Other

Indications

No indication recorded.